Tiantan Biotech (600161.SH)'s net profit of 244 million yuan in the first quarter decreased 22.9% year-on-year

Zhitongcaijing · 04/15 11:33

According to Zhitong Finance App News, Tiantan Biotech (600161.SH) disclosed its early performance report for the first quarter of 2025. During the reporting period, it achieved operating income of 1,318 billion yuan, an increase of 7.84% over the previous year; net profit attributable to shareholders of listed companies was 244 million yuan, a year-on-year decrease of 22.9%.